According to the results of our study, no association was found between the variants in the ATM (rs11212617), SLC22A1 (rs628031), SLC47A1 (rs2289669), and SLC2A2 (rs8192675) genes and the therapeutic response to metformin in the Russian patients with T2DM. The gene discussed is ATM; the disease is type 2 diabetes mellitus.